poisar

Stock

MBX Biosciences, Inc. MBX

$68.14+1.58%

Overview

MBX market data

Price History

MBX price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$2.38
Diluted earnings per share over the trailing twelve months.
Beta
1.47
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$9.63 – $72.64
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $3.2B · P/B 3.84.

Company News

10 captured
Truist Securities Maintains Buy on MBX Biosciences, Raises Price Target to $88Benzinga · Aug 10, 2026, 6:11 PM
MBX Biosciences Q2 EPS $(0.78) Misses $(0.63) EstimateBenzinga · Aug 6, 2026, 12:05 PM
8-K filing — MBX Biosciences, Inc. (MBX)SEC EDGAR · Aug 6, 2026, 12:03 PM
Mizuho Maintains Outperform on MBX Biosciences, Raises Price Target to $91Benzinga · Jul 29, 2026, 3:49 PM
ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On FridayBenzinga · Jul 17, 2026, 2:09 PM
MBX Biosciences shares are trading lower. The company announced the appointment of Steve Hoerter as Chairman and CEO.Benzinga · Jul 14, 2026, 12:59 PM
MBX Biosciences Appoints Steve Hoerter As Chairman And CEO, Succeeding Kent Hawryluk, With John Smither Named Interim CFO, Effective ImmediatelyBenzinga · Jul 13, 2026, 8:19 PM
MBX Biosciences Highlights Sustained Calcium Control In Rare DiseaseBenzinga · Jun 12, 2026, 2:45 PM
Lennar Reports Mixed Q2 Results, Joins Adobe And Other Big Stocks Moving Lower In Friday's Pre-Market SessionBenzinga · Jun 12, 2026, 12:05 PM
MBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic HypoparathyroidismGlobenewswire Inc · Jun 12, 2026, 11:15 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock